EMA – Update of the EMA’s guidance documents on pre-authorisation and post-authorisation procedural advice for users of the centralised procedure
Those two guidance documents in the form of Q&As address a number of questions which users of the centralised procedure may have regarding the pre-authorisation and post-authorisation procedures:
- European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure (web version of the Q&A)
- European Medicines Agency post-authorisation procedural advice for users of the centralised procedure (web versions of the Q&As)
Find more guidance on Marketing authorisation on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (16 mai 2025). EMA – Update of the EMA’s guidance documents on pre-authorisation and post-authorisation procedural advice for users of the centralised procedure. ELSIBI. Consulté le 18 janvier 2026 à l’adresse https://doi.org/10.58079/13xye





